A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients
Clinical trial NCT00862979 · COMPLETED
Trial details
- NCT number
- NCT00862979
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-24
- Primary completion
- 2017-03-06
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.